Get startedLog in
    Picture of Innovent Biologics logo

    1801 — Innovent Biologics News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapHigh Flyer
    All News

    Brief: Innovent Biologics Says NMPA Approved New Drug Application Of Dovbleron

    Picture of Innovent Biologics logoInnovent Biologics
    20/12/2024 11:13
    Dec 20 (Reuters) - Innovent Biologics Inc  1801.HK :
    * NMPA APPROVED NEW DRUG APPLICATION OF DOVBLERON
(TALETRECTINIB
ADIPATE CAPSULE)


Further company coverage:  1801.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Innovent Biologics

    See all news